1,234 Shares in Cardinal Health, Inc. $CAH Purchased by TKG Advisors LLC

TKG Advisors LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 1,234 shares of the company’s stock, valued at approximately $207,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Greykasell Wealth Strategies Inc. acquired a new stake in Cardinal Health in the first quarter worth $26,000. Jones Financial Companies Lllp increased its holdings in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC increased its holdings in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after acquiring an additional 75 shares during the period. NewSquare Capital LLC increased its holdings in shares of Cardinal Health by 100.0% in the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after acquiring an additional 107 shares during the period. Finally, GW&K Investment Management LLC increased its holdings in shares of Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after acquiring an additional 144 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

NYSE CAH opened at $195.30 on Wednesday. Cardinal Health, Inc. has a 12 month low of $110.63 and a 12 month high of $197.67. The firm has a market capitalization of $46.40 billion, a PE ratio of 30.28, a P/E/G ratio of 1.39 and a beta of 0.71. The company’s 50 day simple moving average is $157.00 and its 200 day simple moving average is $155.47.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. During the same period last year, the firm earned $1.88 EPS. The firm’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s payout ratio is presently 30.77%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on CAH shares. Mizuho raised their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research note on Monday. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Argus set a $189.00 target price on Cardinal Health in a research report on Friday, August 22nd. Citigroup raised their target price on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research report on Friday, October 31st. Finally, Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Eleven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $200.54.

Insider Activity

In other news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider owned 48,457 shares of the company’s stock, valued at $7,211,370.74. The trade was a 44.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the transaction, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 271,676 shares of company stock valued at $40,489,525 over the last quarter. Insiders own 0.12% of the company’s stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.